bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.07.29.667538

United States stakeholder insights on genetic testing for equine health and breeding

Mienaltowski, M. J.·Hernandez, S.·Nastrini, E.·Wickens, C. L.·McCue, M. E.·Patterson Rosa, L.·Norton, E. M.·McCoy, A. M.·Brooks, S. A.
View original source ↗Export metadata ↓

Abstract

The S1094 United States Department of Agriculture (USDA) Multistate Research Project is a community of scientists working together to utilize equine genetics and genomics to improve the health and well-being of horses while also providing educational and genetic testing resources to those in the equine industry. To assess the knowledge and priorities of stakeholders regarding genetic testing, we conducted an online survey targeting horse owners and enthusiasts in the United States. Data were collected from March to October 2024 with 412 respondents from 44 states completing the survey. Most of the survey participants were horse owners, and the two most common age ranges for respondents were 31-50 (33.6%) and 51-70 (33.3%) years old. The two most common use categories for horses reported by respondents were sport and stock horses. The survey revealed that a majority of respondents were confident in their knowledge of genetics and that they relied primarily on breed and discipline organizations, as well as universities for their genetic information. Secondarily they relied upon social media and their veterinarians. Respondents expressed significant interest in genetic testing for diversity and performance traits. Across all horse use categories, arthritis, colic and intestinal disease, laminitis, metabolic disorders, and tendon and ligament issues had the greatest level of concern - all of which are complex genetic traits and will require collaborative efforts to discern levels of genetic involvement. Results from the survey underscore the need for continued outreach and education of horse owners, as well as further development of genetic testing tools to support informed decision-making among stakeholders in the equine industry. Lay SummaryGenetic testing helps horse owners, breeders, and breed registries and associations verify parentage, evaluate health, and improve performance. The S1094 USDA Multistate Research Project has a mission of improving genomics and genetics tools, as well as providing educational resources for those in the equine industry. To better understand the knowledge and priorities of stakeholders in the equine industry, we conducted an online survey netting responses from 412 individuals in the United States. Respondents were primarily horse owners who self-identified as confident in their knowledge of horse genetics. Furthermore, those responding indicated that their primary resources for information about genetics were breed and discipline association websites and universities. They also expressed interest in genetic testing for diversity and performance traits. Across all horse use categories, arthritis, colic and intestinal disease, laminitis, metabolic disorders, and tendon and ligament issues had the greatest level of concern. Given the complex nature of these conditions, collaborative efforts will be required to discern levels of genetic involvement. Respondents felt that genetic testing and education efforts have significant impacts on the equine industry because they aid owners in making breeding decisions and in the management of horse health and well-being. Teaser TextThis nationwide survey of U.S. horse owners discerned strong stakeholder interest in equine genetic testing, determined sources for knowledge acquisition, and highlighted key priorities for the development of genetic tools and educational materials.

Source connections

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mienaltowski, M. J., Hernandez, S., Nastrini, E., Wickens, C. L., McCue, M. E., Patterson Rosa, L., Norton, E. M., McCoy, A. M., Brooks, S. A.. 2025-08-06. United States stakeholder insights on genetic testing for equine health and breeding. https://doi.org/10.1101/2025.07.29.667538

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Large language model-based bibliometric evaluation of population descriptors in human genetics

As the use of population descriptors such as race, ethnicity, and ancestry have become increasingly common in modern genetics research, there have been growing calls to critically examine their use. Most notably, in 2023, the National Academies of Science, Engineering, and Medicine (NASEM) published a report titled Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field, which included eight specific and actionable recommendations for researchers to implement the ethical and accurate use of population descriptors in genetic research. Here, we use the 2023 NASEM report as a benchmark to analyze the use of population descriptors in genome-wide association studies (GWAS). We develop a general toolkit for large language model-based bibliometrics, operationalize the report's recommendations into an evaluation framework, and apply this framework to evaluate all 4,007 papers from the GWAS Catalog published between 2007 and 2025 with full text available on PubMedCentral. We find significant improvements in adherence to NASEM report recommendations over time. However, most improvements predate the publication of the NASEM report itself, suggesting the report functioned primarily as a synthesis of existing best practices rather than a catalyst for change. We conclude by highlighting opportunities for growth in the field of human genetics.

genetics↗
bioRxiv2026

Mitigating biases of rescaling in forward-in-time population genetic simulations

Forward-in-time population genetic simulations are widely used in evolutionary analyses, but simulating large populations and long genomic regions remains computationally demanding. To reduce this cost, parameter rescaling is widely employed, in which the original evolutionary process is approximated by one with a smaller population size and fewer generations. Recently, several studies using the SLiM simulator have raised concerns about the accuracy of this rescaling approach. In this study, we show that many of the biases reported in these studies can be mitigated by using a different simulation algorithm. These results reveal that the accuracy of parameter rescaling depends on how well the simulation algorithm preserves diffusion-limit properties under rescaling.

genetics↗
bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗